Abstract
Objective To summarize the relationship between metabolic syndrome(MS), its components and T1 stage with high grade urothelial carcinoma (HGUC) of the Bladder. Methods The clinical data of 200 patients with T1 high grade bladder cancer who were admitted to our hospital from January 2010 to June 2014 were retrospectively analyzed, including 155 males and 45 females. Ages were 24 to 86 years old, average 66 years old. Based on the history or blood glucose levels, patients were divided into diabetic group (n = 41) (20.5%) and non diabetes group 159 cases (79.5%); According to the body mass index (BMI) were divided into obese group (≥25 kg / m2) of 98 cases (49.0%) and non obese group (< 25 kg / m2) of 102 cases (51.0%). According to the blood pressure level, 71 cases (35.5%) were divided into hypertension group and 129 cases of non hypertension group (64.5%). MS and its components and the relationship between the recurrence and progress of bladder cancer were analyzed. The Kaplan Meier method was used to assess MS and its components division of tumor progression free survival (progress-free survival, PFS) and recurrence free survival (recurrence-free survival, RFS) influence. Cox regression model of multi factor analysis were used to evaluate the PFS and RFs of MS and its components with bladder cancer. Results Of the 200 cases, 16 cases (8.0%) were MS. Tumor recurrence occurred in 121 cases (60.5%), and 84 patients (42.0%) were in progress. Diabetes and non diabetes groups the average RFs were 21.7 and 29.3 months respectively, and the difference was statistically significant (χ2=10.115, P=0.001); The median PFS were 32.8 and 39.8 months respectively, the difference has statistical significance (χ2=14.760, P<0.001). Obese group and non obese group average RFs were 34.7 and 42.0 months respectively, and the difference were statistically significant (χ2=16.077, P<0.001); The median PFS were 22.8 and 32.6 months respectively, the difference was statistically significant (χ2=16.174, P<0.001). The average RFS of MS group and non MS group were 21.5 and 28.4 months respectively, the difference was statistically significant (χ2=5.429, P=0.02); the average PFS was 35.1 and 38.7 months respectively, and the difference was statistically significant (χ2=3.854, P<0.05). Cox multivariate survival analysis showed that diabetes and obesity can increase the risk of recurrence and progression of T1 advanced stage bladder cancer (HR=1.792, P=0.013, HR=2.498, P<0.001; HR=0.559, P<0.001; HR=0.492, P<0.001). Conclusions Diabetes mellitus and obesity are high risk factors for the recurrence and progression of T1 advanced stage bladder cancer, but MS is not related to the prognosis of T1 patients with advanced bladder cancer. Key words: Metabolic syndrome; Urothelial carcinoma; Diabetes mellitus; Hypertension; Obesity
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have